Top compounds associated with response to LRRC47


Feature Type Standardized
Nominal ANOVA
mRNA BMS-270394 CTRPv2 pan-cancer AAC 0.041 0.3
mRNA Pyrimethamine GDSC1000 pan-cancer AAC 0.055 0.3
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.041 0.3
mRNA Bortezomib GDSC1000 pan-cancer AAC -0.052 0.3
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.038 0.3
mRNA XMD11-85h GDSC1000 pan-cancer AAC -0.05 0.3
mRNA Platin CTRPv2 pan-cancer AAC -0.041 0.3
mRNA hyperforin CTRPv2 pan-cancer AAC 0.042 0.3
mRNA Doxorubicin GDSC1000 pan-cancer AAC 0.037 0.3
mRNA isoliquiritigenin CTRPv2 pan-cancer AAC 0.071 0.3
Download CSV